Skip to main content
. 2020 Jun;63(3):E241–E249. doi: 10.1503/cjs.002719

Table 1.

Patient demographic and clinical characteristics

Characteristic No. (%) of patients* p value
All
n = 150
Grade I cholecystitis
n = 104
Grade II and III cholecystitis
n = 46
Sex, female 91 (60.7) 68 (65.4) 23 (50.0) 0.11
Age, yr, mean (range) 51.5 (20–90) 50.2 (20–87) 54.4 (24–90) 0.14
Comorbidities
 Obesity 58 (39.3) 41 (39.4) 17 (37.0) 0.86
 CAD 13 (8.6) 9 (8.7) 4 (8.7) 1.00
 COPD 5 (3.3) 4 (3.8) 1 (2.2) 1.00
 OSA 7 (4.7) 5 (4.8) 2 (4.3) 1.00
 Asthma 10 (6.7) 10 (6.7) 0 (0) 0.032
 Current smoker 39 (26.0) 25 (24.0) 14 (30.4) 0.42
 Type 2 diabetes 23 (15.3) 11 (10.6) 12 (26.1) 0.025
AACCI score
 0 47 (31.3) 33 (31.7) 14 (30.4) 1.00
 1–5 97 (64.7) 66 (63.5) 31 (67.4) 1.00
 6–10 6 (4.0) 5 (4.8) 1 (2.2) 0.67
 Median (range)§ 1 (0–9) 1 (0–7) 1.5 (0–9) 0.22
ASA score
 1 5 (3.3) 3 (2.8) 2 (4.3) 0.64
 2 41 (27.3) 29 (27.9) 12 (26.1) 1.00
 3 89 (59.3) 63 (60.6) 26 (56.5) 0.72
 4 15 (10.0) 9 (8.7) 6 (13.0) 0.39

AACCI = Age-adjusted Charlson Comorbidity Index; ASA = American Society of Anesthesiologists; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; OSA = obstructive sleep apnea.

*

Unless indicated otherwise.

Independent samples t test.

Fisher exact test.

§

Mann–Whitney U test.